000			01932nam a2200373Ia 4500
001			ocm47755624
003			OCoLC
005			20180511125017.0
007			he bmb024bbca
008			010810s2000 dcua b f000 0 eng d
040			_aFPS _beng _cFPS _dOCLCQ _dOCLCF _dOCLCO _dOCLCQ _dOCLCO _dOCLCQ _dGPO _dMvI
043			_an-us---
074			_a1019-B-01 (MF)
086	0		_aY 4.C 73/8:106-164
099			_aY 4.C 73/8:106-164
110	1		_aUnited States. _bCongress. _bHouse. _bCommittee on Commerce. _bSubcommittee on Oversight and Investigations.
245	1	0	_aCounterfeit bulk drugs : _bhearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Sixth Congress, second session, June 8 and October 3, 2000.
260			_aWashington : _bU.S. G.P.O. : _bFor sale by the Supt. of Docs., Congressional Sales Office, U.S. G.P.O., _c2000.
300			_aiii, 423 pages : _billustrations ; _c24 cm
336			_atext _btxt _2rdacontent
337			_amicroform _bh _2rdamedia
338			_amicrofiche _bhe _2rdacarrier
500			_a"Serial no. 106-164."
500			_aShipping list no not available.
500			_aCRDP Program record.
533			_aMicrofiche. _bWashington : _cU.S. G.P.O., _d2001. _e5 microfiches : negative.
650		0	_aDrugs _xInspection _zUnited States.
650		0	_aDrugs _xStandards _zUnited States.
650		0	_aDrug adulteration _xGovernment policy _zUnited States.
650		0	_aPharmaceutical industry _zUnited States _xQuality control.
650		0	_aProduct counterfeiting _zUnited States.
776	0	8	_iOnline version: _aUnited States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations. _tCounterfeit bulk drugs _w(OCoLC)852783298
776	0	8	_iPrint version: _aUnited States. Congress. House. Committee on Commerce. Subcommittee on Oversight and Investigations. _tCounterfeit bulk drugs _w(OCoLC)503594555
999			_c271008 _d271008